The Patent Finder

Approach for Treatment of Cancer via Immunomodulation by Using Talabostat

Onkosxcel Therapeutics, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,564,986Approach for Treatment of Cancer via Immunomodulation by Using Talabostat
In force
 · High confidence
Onkosxcel Therapeutics, LLCIn forceHigh confidence
Application 18/069,489Approach for Treatment of Cancer via Immunomodulation by Using Talabostat
Abandoned
Abandoned Oct 16, 2024
Jazz Pharmaceuticals Ireland LimitedAbandonedAbandoned Oct 16, 2024
Application 18/802,908Novel Approach for Treatment of Cancer Using Immunomodulation
Pending
Not granted
OnkosXcel Therapeutics, LLCPendingNot granted
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Onkosxcel Therapeutics, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited